InvestorsHub Logo
Followers 4
Posts 589
Boards Moderated 0
Alias Born 03/07/2003

Re: Tungsten post# 463

Friday, 09/03/2010 11:29:04 AM

Friday, September 03, 2010 11:29:04 AM

Post# of 22684
I hope you do some dd on the other stocks about which you might have an opinion, because you seem to have done less than none about lorcaserin and the FDA guidelines for obesity drugs. There are two benchmarks the FDA has established, with an EITHER qualifier, for an obesity drug application. Lorcaserin beat one of these and is therefore fully qualified on the efficacy front. And it's not just 'more safe" (your grudging concession) than Qnexa, it is essentially as safe as placebo with over 8000 patients tested, half of them over two years, and all with extensive safety analysis over the course of the trials.

I hope you were fudging with your position disclosure and that you are in fact short up to the hilt waiting for your $3 bonanza.